Jisun Jeong1, Sun Woong Kim1, Duk Hyun Sung2. 1. Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Ilwon-ro, Gangnam-gu, Seoul, 06351, Korea. 2. Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Ilwon-ro, Gangnam-gu, Seoul, 06351, Korea. yays.sung@samsung.com.
Abstract
OBJECTIVES: Neurolymphomatosis (NL) is a disease characterized by the infiltration of malignant lymphocytes into the peripheral nervous system. We report clinical features, radiographic findings, modes of treatment, and outcomes of patients with NL. METHODS: We retrospectively investigated patients with NL. We extracted data, including clinical features, magnetic resolution imaging (MRI), 18F-fludeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scans, cerebrospinal fluid cytology findings, the results of electrodiagnostic studies, as well as patient treatments and outcomes. RESULTS: Ten NL patients were identified. All patients reported pain/paresthesia and weakness in the affected area. The MRI scans were abnormal in eight out of nine patients with an enhancement of the spinal nerve root, plexus, peripheral nerve trunk, and cranial nerve. The FDG PET/CT scans were positive in all patients. Radiculopathy or radiculoplexopathy was the most common electrodiagnostic finding. Neurological improvement was observed in only three patients. The condition of the nine patients who underwent multimodality treatments for cancer eventually deteriorated and the patients died. CONCLUSIONS: NL should be considered in the differential diagnosis of any type of neuropathy in patients with lymphoma. Because it could be confused with other neuropathies in lymphoma and various musculoskeletal diseases, a high index of suspicion and familiarity with clinical manifestation of NL are key. FDG PET/CT was the most sensitive diagnostic imaging modality to detect relevant neural invasion. The root within the spinal neural foramen was the most frequently affected neural structure. Early diagnosis of this rare neurologic manifestation of lymphoma may improve treatment outcomes.
OBJECTIVES:Neurolymphomatosis (NL) is a disease characterized by the infiltration of malignant lymphocytes into the peripheral nervous system. We report clinical features, radiographic findings, modes of treatment, and outcomes of patients with NL. METHODS: We retrospectively investigated patients with NL. We extracted data, including clinical features, magnetic resolution imaging (MRI), 18F-fludeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scans, cerebrospinal fluid cytology findings, the results of electrodiagnostic studies, as well as patient treatments and outcomes. RESULTS: Ten NL patients were identified. All patients reported pain/paresthesia and weakness in the affected area. The MRI scans were abnormal in eight out of nine patients with an enhancement of the spinal nerve root, plexus, peripheral nerve trunk, and cranial nerve. The FDG PET/CT scans were positive in all patients. Radiculopathy or radiculoplexopathy was the most common electrodiagnostic finding. Neurological improvement was observed in only three patients. The condition of the nine patients who underwent multimodality treatments for cancer eventually deteriorated and the patients died. CONCLUSIONS: NL should be considered in the differential diagnosis of any type of neuropathy in patients with lymphoma. Because it could be confused with other neuropathies in lymphoma and various musculoskeletal diseases, a high index of suspicion and familiarity with clinical manifestation of NL are key. FDG PET/CT was the most sensitive diagnostic imaging modality to detect relevant neural invasion. The root within the spinal neural foramen was the most frequently affected neural structure. Early diagnosis of this rare neurologic manifestation of lymphoma may improve treatment outcomes.
Entities:
Keywords:
FDG-PET/CT; Lymphoma; MRI; Neurolymphomatosis; Peripheral nervous system
Authors: Sigal Grisariu; Batia Avni; Tracy T Batchelor; Martin J van den Bent; Felix Bokstein; David Schiff; Outi Kuittinen; Marc C Chamberlain; Patrick Roth; Anatoly Nemets; Edna Shalom; Dina Ben-Yehuda; Tali Siegal Journal: Blood Date: 2010-04-05 Impact factor: 22.113
Authors: Anthony Tien Hoe Lim; Danielle Clucas; Christine Khoo; Bimal Kumar Parameswaran; Eddie Lau Journal: J Med Imaging Radiat Oncol Date: 2015-05-13 Impact factor: 1.735
Authors: Joachim M Baehring; Denise Damek; Emily C Martin; Rebecca A Betensky; Fred H Hochberg Journal: Neuro Oncol Date: 2003-04 Impact factor: 12.300
Authors: Ja Min Byun; Ki Hwan Kim; Miso Kim; Tae Min Kim; Yoon Kyung Jeon; Jeong Hwan Park; Jin Ho Paik; Jung Min Lee; Ho-Young Lee; Jong Seok Lee; Dae Seog Heo; Jeong-Ok Lee Journal: Leuk Lymphoma Date: 2017-05-09
Authors: Carlos Kamiya-Matsuoka; Sheetal Shroff; Kasey Gildersleeve; Bahram Hormozdi; John T Manning; Karin H Woodman Journal: J Neurol Sci Date: 2014-06-02 Impact factor: 3.181
Authors: K Viala; A Béhin; T Maisonobe; J-M Léger; T Stojkovic; F Davi; V Leblond; P Bouche Journal: J Neurol Neurosurg Psychiatry Date: 2007-10-30 Impact factor: 10.154
Authors: R Diaz-Arrastia; D S Younger; L Hair; G Inghirami; A P Hays; D M Knowles; J G Odel; M R Fetell; R E Lovelace; L P Rowland Journal: Neurology Date: 1992-06 Impact factor: 9.910